ImportRefusal LogoImportRefusal

Latina Pharma S.p.A.

⚠️ Moderate Risk

FEI: 3001229385 • Sermoneta, Latina • ITALY

FEI

FEI Number

3001229385

📍

Location

Sermoneta, Latina

🇮🇹

Country

ITALY
🏢

Address

Via Murillo 7, , Sermoneta, Latina, Italy

Moderate Risk

FDA Import Risk Assessment

43.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
4
Unique Violations
12/20/2022
Latest Refusal
4/26/2012
Earliest Refusal

Score Breakdown

Violation Severity
75.7×40%
Refusal Volume
25.9×30%
Recency
24.0×20%
Frequency
3.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
12/20/2022
58DCF99ANTINEOPLASTIC, NEC
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/1/2016
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
75UNAPPROVED
Division of Northern Border Imports (DNBI)
8/14/2015
62IIS25LOMUSTINE (ANTI-NEOPLASTIC)
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/26/2012
56BCH03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Latina Pharma S.p.A.'s FDA import refusal history?

Latina Pharma S.p.A. (FEI: 3001229385) has 4 FDA import refusal record(s) in our database, spanning from 4/26/2012 to 12/20/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Latina Pharma S.p.A.'s FEI number is 3001229385.

What types of violations has Latina Pharma S.p.A. received?

Latina Pharma S.p.A. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Latina Pharma S.p.A. come from?

All FDA import refusal data for Latina Pharma S.p.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.